Q4 2023 Holdings
Filed 2024-02-14 | 38 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $163.9M | 5,714,775 | 16.1% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $141.5M | 8,707,165 | 13.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $97.1M | 1,006,500 | 9.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $81.3M | 7,387,943 | 8.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $44.5M | 1,091,867 | 4.4% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $44.2M | 1,450,000 | 4.3% |
| Illumina Inc(ILMN) | COM | 452327109 | $43.6M | 313,000 | 4.3% |
| Verve Therapeutics Inc | COM | 92539P101 | $41.9M | 3,009,094 | 4.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $37.3M | 195,000 | 3.7% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $31.9M | 12,604,275 | 3.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $31.1M | 420,000 | 3.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $30.1M | 326,378 | 3.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $28.6M | 1,577,108 | 2.8% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $27.9M | 1,300,000 | 2.7% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $20.9M | 1,033,811 | 2.1% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $20.7M | 6,381,377 | 2.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $14.4M | 528,000 | 1.4% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $13.5M | 2,360,129 | 1.3% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $11.8M | 1,188,349 | 1.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $10.6M | 3,206,380 | 1.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $10.6M | 1,175,750 | 1.0% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $10.2M | 524,616 | 1.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $10.2M | 1,035,859 | 1.0% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $8.5M | 3,095,511 | 0.8% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $7.7M | 2,050,000 | 0.8% |
| Codexis Inc(CDXS) | COM | 192005106 | $6.1M | 2,000,000 | 0.6% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $5.0M | 1,182,623 | 0.5% |
| Absci Corporation(ABSI) | COM | 00091E109 | $4.1M | 973,260 | 0.4% |
| Illumina Inc(ILMN)Call | COM | 452327109 | $3.5M | 25,000 | 0.3% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $3.3M | 367,175 | 0.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.2M | 150,000 | 0.3% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $2.9M | 510,882 | 0.3% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $2.7M | 1,200,000 | 0.3% |
| Exscientia PLC | ADS | 30223G102 | $1.4M | 213,900 | 0.1% |
| Structure Therapeutics Inc(GPCR)Call | SPONSORED ADS | 86366E106 | $1.0M | 25,000 | 0.1% |
| Lianbio | SPONSORED ADS | 53000N108 | $922.7K | 206,415 | 0.1% |
| Singular Genomics Systems in | COM | 82933R100 | $609.1K | 1,323,885 | 0.1% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $154.8K | 123,839 | 0.0% |